Table 1.

In vitro susceptibility of Gram-positive pathogens to JNJ-Q2 and comparators in the mouse infection models

Drug	MIC (μg/ml)
	S. pneumoniae ATCC 6301	MSSA ATCC 13709	MRSA OC 8525	MRSA ATCC 43300
JNJ-Q2	0.015	0.008	0.015	0.004
Ciprofloxacin	0.25	0.25	2	0.5
Moxifloxacin	0.25	0.06	0.25	0.03
Gemifloxacin	0.03	0.008	0.06	0.03
Linezolid	1	4	4	2
Vancomycin	0.5	1	1	1